Name: | 1-Naphthacenecarboxylicacid,2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-(dimethylamino)-a-L-lyxo-hexopyranosyl]oxy]-,methyl ester, (1R,2R,4S)- |
Synonyms: | 1-Naphthacenecarboxylicacid,2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-(dimethylamino)-a-L-lyxo-hexopyranosyl]oxy]-,methyl ester, [1R-(1a,2b,4b)]-; 1-Deoxypyrromycin; Aclacinomycin T; Aklavin; Aklavine;Antibiotic MA 144T1; MA 144T1 |
InChI: | InChI=1/C30H35NO10.ClH/c1-6-30(38)12-19(41-20-11-17(31(3)4)25(33)13(2)40-20)22-15(24(30)29(37)39-5)10-16-23(28(22)36)27(35)21-14(26(16)34)8-7-9-18(21)32;/h7-10,13,17,19-20,24-25,32-33,36,38H,6,11-12H2,1-5H3;1H/t13-,17-,19-,20-,24-,25+,30+;/m0./s1 |
Specification: |
1-Deoxypyrromycin with cas registry number of 60504-57-6 is also known as Methyl (1R,2R,4S)-4-[(2S,4S,5S,6S)-4-dimethylamino-5-hydroxy-6-methyl- oxan-2-yl]oxy-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1H-tetra cene-1-carboxylate ; (1R)-2-Ethyl-1,2,3,4,6,11-hexahydro-2α,5,7-trihydroxy-4α-[[3-(dimethylamino)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-6,11-dioxonaphthacene-1β-carboxylic acid methyl ester ; (1R)-2-Ethyl-1,2,3,4,6,11-hexahydro-2α,5,7-trihydroxy-6,11-dioxo-4α-[[2,3,6-trideoxy-3-dimethylamino-α-L-lyxo-hexopyranosyl]oxy]naphthacene-1β-carboxylic acid methyl ester ; (1R)-2-Ethyl-2α,5,7-trihydroxy-4α-[[3-(dimethylamino)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacene-1β-carboxylic acid methyl ester ; Aclacinomycin T ; Aklavin ; MA-144T1 . It is a drug mutagen natural product. 1-Deoxypyrromycin with cas registry number of 60504-57-6 is used as an intermediate in synthesis of many useful compounds.
|